• Mutual Funds
  • Nippon Mutual Fund
  • Nippon India Pharma Fund (PIDCW)

Formerly Nippon India Pharma DP

Nippon Mutual Fund

Nippon India Pharma Fund (PIDCW)

EquitySectoral / Thematic - Pharma And Healthcare


NAV (Oct 03)

5 Year CAGR
Scripbox Opinion
Click here for top ranked funds in sectoral / thematic - pharma and healthcare mutual funds.

Sectoral / thematic - pharma and healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).

The pharma benchmark index itself has been a material underperformer over an extended time frame.

Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.

Scripbox does not recommend investing in the dividend option of a fund because dividends are taxable at a higher rate than withdrawals.

Our analysis of this fundLearn how we rate funds ->

Fund Size

Category Leader

The fund has been a Category Leader on the Fund Size metric

Outperformance Consistency


The performance of the fund on a Outperformance Consistency metric has been Neutral

Invest in this fund
Scripbox Recommended Equity Funds
Want the equity funds that are right for your long term equity investment needs?Learn more
Parag Parikh Flexi Cap Regular Growth
17.1%5Y CAGR
HDFC Large and Mid Cap Fund Growth
12.7%5Y CAGR
PGIM India Midcap Opportunities Fund Regular Growth
15.8%5Y CAGR
Canara Robeco Bluechip Equity Fund Regular Plan Growth
12.4%5Y CAGR

Investment Calculator

Investment Duration5 years


Total Investment


Wealth Gained


Total Corpus Created (₹)

With CAGR of 11.25 % in 5 years

Historical NAV


NAV (Oct 3)

Fund Returns

Last 1Y
Last 3Y
Last 5Y
Last 10Y
Since Inception
6 Month CAGR

Scheme Information

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Expense Ratio
Launched (19y ago)
Jun 05, 2004
AUM in Crores
No Lock-in
S&P BSE Healthcare TR INR
SIP Minimum
Lumpsum Min.
Standard Deviation (3yr)
Standard Deviation (5yr)
Beta (3yr)
Beta (5yr)
Sharpe Ratio (3yr)
Sharpe Ratio (5yr)
Fund Managers

Kinjal Desai

Fund Manager

Sailesh Raj Bhan

Fund Manager

Akshay Sharma

Fund Manager

Returns Calculator Comparison



with step up of

AssetReturnsTotal CorpusGainsCAGR
Nippon India Pharma Fund (PIDCW)70%12,06,850 4,74,23819.7%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Asset allocation and Holdings

Last updated on 2023-10-03

Top Stock Holdings

See all holdings

Comparison with Equity Funds

Fund NameFund SizeOutperformance Consistency
Mirae Asset Tax Saver Fund (G)
Mirae Asset Tax Saver Fund (G)

₹ 17,630 cr

₹ 11,197 cr

₹ 11,862 cr

₹ 10,089 cr

₹ 9,392 cr

About the AMC

Nippon Life India Asset Management Ltd

Nippon Life India Asset Management Ltd manages assets worth 293,057 crores and was set up on 24 February 1995. It's current offering of mutual fund schemes includes 99 equity,377 debt and 32 hybrid funds.amc-img
Fund NameScripbox Opinion
Till Date CAGR











Nippon India Pharma Fund (PIDCW) Review

Nippon India Pharma Fund (PIDCW) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 20.9% over a period of 19 years. The fund was previously known as Nippon India Pharma DP. The fund is managed by Nippon Life India Asset Management Ltd. The fund managers are Akshay Sharma, Kinjal Desai, Sailesh Raj Bhan.

Nav of Nippon India Pharma Fund (PIDCW) as of 10/3/2023 is ₹97.51 with the total AUM as of 10/4/2023 is ₹5544.916. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Pharma Fund (PIDCW) was launched on Jun 05, 2004. The category risk of the fund is Very High Risk.

The minimum SIP amount for Nippon India Pharma Fund (PIDCW) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

Nippon India Pharma Fund (PIDCW) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to S&P BSE Healthcare TR INR.

Nippon India Pharma Fund (PIDCW) is rated as a 2 fund in Equity and delivered 25.9% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Pharma Fund (PIDCW).

Frequently Asked Questions

What is Nippon India Pharma Fund (PIDCW)?

Nippon India Pharma Fund (PIDCW) is a Sectoral / Thematic - Pharma And Healthcare Equity scheme predominantly investing across Equity instruments with an investment objective to generate wealth over the long term.

How to invest in Nippon India Pharma Fund (PIDCW)?

You can invest in Nippon India Pharma Fund (PIDCW) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?

What is the minimum sip amount of Nippon India Pharma Fund (PIDCW)?

The minimum sip amount for Nippon India Pharma Fund (PIDCW) is ₹1000. You can invest in multiples of ₹5000.

Is Nippon India Pharma Fund (PIDCW) good to invest in?

As per Scripbox experts, Nippon India Pharma Fund (PIDCW) is a Neutral fund. You can investNippon India Pharma Fund (PIDCW) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.

What is the expense ratio of the Nippon India Pharma Fund (PIDCW)?

The expense ratio of the Nippon India Pharma Fund (PIDCW) is 1.89% for regular plan.